Novavax’s COVID-19 booster is now authorized in Europe

0
8

Shares of Novavax Inc. NVAX, +0.35% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax’s stock has declined 77.3% so far this year, while the S&P 500 SPX, +0.96% is down 14.6%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleMarket Snapshot: U.S. stock futures point to fourth day of gains for Wall Street
Next articleAll but one Dow stock in positive territory as index runs up gain of 350 points

LEAVE A REPLY

Please enter your comment!
Please enter your name here